Eastman Chemical

US · EMN #1730 by market cap Listed 1970

63.25 -0.86 -1.34%

Live - 5344 symbols - heartbeat 305s ago · 2026-10-07 19:54

After-hours 63.25 0.00%

Market cap: 7.23B
P/E (TTM): 16.47
P/B: 1.19
EPS: 4.10
Div yield: 5.30%
52W pos: 36%

Reader sentiment Are you bullish or bearish on EMN?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Fair

Altman Z-Score is 2.33, in the 1.8-3.0 "grey zone".
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year -6.72% YoY

Margins

Gross margin: 21.07%
Operating margin: 10.92%
Net margin: 5.42%

Key ratios & quality

Enterprise value: 11.46B
Altman Z-Score: 2.33

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	10.15B	9.27B	8.47B	10.48B	10.58B	9.21B	9.38B	8.75B
Gross profit	2.48B	2.23B	1.98B	2.50B	2.14B	2.06B	2.29B	1.84B
Selling & admin expenses	721.00M	691.00M	654.00M	383.00M	625.00M	768.00M	664.00M	633.00M
Research & development	235.00M	234.00M	226.00M	254.00M	264.00M	239.00M	250.00M	255.00M
Operating profit	1.52B	1.31B	1.10B	1.86B	1.25B	1.05B	1.38B	956.00M
Pretax profit	1.31B	902.00M	530.00M	1.08B	977.00M	1.09B	1.08B	568.00M
Tax	226.00M	140.00M	41.00M	215.00M	181.00M	191.00M	170.00M	93.00M
Net profit	1.08B	762.00M	489.00M	867.00M	796.00M	896.00M	908.00M	475.00M
Basic EPS	8	6	4	6	6	8	8	4
Diluted EPS	7.56	5.48	3.50	6.25	6.35	7.49	7.67	4.10

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	2.29B	2.29B	2.20B	1.97B	2.18B	2.51B
Gross profit	567.00M	506.00M	433.00M	338.00M	431.00M	560.00M
Selling & admin expenses	182.00M	155.00M	160.00M	134.00M	178.00M	169.00M
Research & development	67.00M	67.00M	63.00M	58.00M	60.00M	65.00M
Operating profit	318.00M	284.00M	210.00M	146.00M	193.00M	326.00M
Pretax profit	253.00M	169.00M	134.00M	12.00M	136.00M	256.00M
Tax	70.00M	29.00M	87.00M	-93.00M	29.00M	72.00M
Net profit	183.00M	140.00M	47.00M	105.00M	107.00M	184.00M
Basic EPS	2	1	0	1	1	2
Diluted EPS	1.57	1.20	0.40	0.92	0.93	1.59

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	3.37B	3.32B	3.54B	4.65B	3.78B	3.48B	4.10B	3.65B
Cash & ST investments	226.00M	204.00M	564.00M	459.00M	493.00M	548.00M	837.00M	566.00M
Inventory	1.58B	1.66B	1.38B	1.50B	1.89B	1.68B	1.99B	1.98B
Total assets	16.00B	16.01B	16.08B	15.52B	14.67B	14.63B	15.21B	14.86B
Total current liabilities	1.85B	1.79B	2.04B	2.97B	3.25B	2.58B	2.71B	2.65B
Short-term debt	243.00M	171.00M	349.00M	747.00M	1.13B	541.00M	450.00M	586.00M
Long-term debt	5.93B	5.61B	5.27B	4.41B	4.03B	4.31B	4.57B	4.20B
Total liabilities	10,117,000,000.00	9,976,000,000.00	9,975,000,000.00	9,731,000,000.00	9,431,000,000.00	9,103,000,000.00	9,361,000,000.00	8,822,000,000.00
Total equity	5.88B	6.03B	6.11B	5.79B	5.24B	5.53B	5.85B	6.04B
Retained earnings	7.57B	7.97B	8.08B	8.56B	8.97B	9.49B	10.01B	10.11B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	3.90B	4.02B	3.79B	3.65B	4.06B	4.26B
Cash & ST investments	418.00M	423.00M	489.00M	566.00M	665.00M	691.00M
Inventory	2.12B	2.15B	1.94B	1.98B	2.08B	2.10B
Total assets	14.97B	15.22B	14.98B	14.86B	15.22B	15.42B
Total current liabilities	2.27B	2.39B	2.16B	2.65B	2.77B	2.84B
Short-term debt	285.00M	344.00M	290.00M	586.00M	770.00M	765.00M
Long-term debt	4.74B	4.78B	4.79B	4.20B	4.45B	4.45B
Total liabilities	9,027,000,000.00	9,313,000,000.00	9,136,000,000.00	8,822,000,000.00	9,136,000,000.00	9,249,000,000.00
Total equity	5.94B	5.91B	5.84B	6.04B	6.09B	6.18B
Retained earnings	10.10B	10.14B	10.10B	10.11B	10.11B	10.20B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	1.54B	1.50B	1.46B	1.62B	975.00M	1.37B	1.29B	970.00M
Depreciation & amortization	604.00M	611.00M	574.00M	538.00M	477.00M	498.00M	509.00M	513.00M
Free cash flow	1.02B	1.07B	1.06B	1.04B	364.00M	546.00M	688.00M	424.00M
Dividends paid	-318.00M	-343.00M	-358.00M	-375.00M	-381.00M	-376.00M	-379.00M	-381.00M
Stock buybacks / issuance	-400.00M	-325.00M	-60.00M	-1.00B	-1.00B	-150.00M	-300.00M	-100.00M
Ending cash balance	226.00M	204.00M	564.00M	459.00M	493.00M	548.00M	837.00M	566.00M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	-167.00M	233.00M	402.00M	502.00M	-137.00M	224.00M
Depreciation & amortization	126.00M	127.00M	129.00M	131.00M	131.00M	132.00M
Free cash flow	-314.00M	83.00M	265.00M	390.00M	-240.00M	124.00M
Dividends paid	-96.00M	-95.00M	-96.00M	-94.00M	-96.00M	-96.00M
Stock buybacks / issuance	--	--	-50.00M	0	--	--
Ending cash balance	418.00M	423.00M	489.00M	566.00M	665.00M	691.00M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	19.28	12.91	7.98	14.62	14.61	16.85	16.11	8.08
ROA %	6.75	4.74	2.98	5.42	5.25	6.10	6.06	3.15
ROIC %	10.66	7.95	5.74	9.02	8.89	10.39	10.17	6.02
5-year avg ROE %	22.12	20.59	17.64	16.53	13.88	13.39	14.03	14.05
EBIT margin %	15.25	12.11	8.78	12.25	11.01	14.25	13.79	8.99
FCF / sales %	10.00	11.64	12.65	9.94	3.32	5.87	7.33	4.84
Current ratio	1.82	1.86	1.74	1.56	1.16	1.35	1.51	1.37
Quick ratio	0.92	0.88	1.02	0.69	0.54	0.66	0.74	0.59
Debt / assets	38.56	36.12	34.93	33.24	35.12	33.12	32.98	32.22
LT debt / equity	102.10	94.18	87.48	77.35	78.11	78.88	79.03	70.47
Interest coverage	6.50	5.08	3.48	6.38	6.20	5.83	5.99	3.59
Revenue CAGR (3Y) %	1.71	0.97	-3.91	1.06	4.49	2.82	-3.61	-6.13
Net income CAGR (3Y) %	8.40	-3.85	-29.84	-7.42	1.47	23.21	1.83	-15.76
FCF CAGR (3Y) %	1.45	12.23	1.66	0.85	-30.26	-19.81	-12.89	5.22

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	16.16	14.52	12.24	8.08	6.72	7.41
ROA %	6.20	5.52	4.65	3.15	2.64	2.88
ROIC %	10.11	9.27	8.07	6.02	5.30	5.54
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	14.24	13.11	11.90	8.99	7.77	8.56
FCF / sales %	6.14	4.37	4.38	4.84	5.76	6.08
Current ratio	1.72	1.68	1.76	1.37	1.47	1.50
Quick ratio	0.74	0.74	0.82	0.59	0.68	0.72
Debt / assets	33.54	33.68	33.88	32.22	34.29	33.82
LT debt / equity	80.67	81.95	82.91	70.47	74.06	73.03
Interest coverage	6.17	5.58	4.86	3.59	3.05	3.43
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Diversified

Advanced materials is the largest reported line at 32.51% of revenue, across 5 reported segments.
No single line clears half of revenue; Additives & Functional Products is next at 32.11%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

Advanced materials32.51%

Additives & Functional Products32.11%

Chemical Intermediates25.59%

Fibers9.67%

Other0.12%

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.